Yukina Shirai
2PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Sep 09, 2024
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.Birgit Wilding, Lydia Woelflingseder, Anke Baum
|May 24, 2024
A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency.Shinji Kohsaka, Shigehiro Yagishita, Yukina Shirai
Pageof 1
Frequent Collaborators
2 joint publications
Shinji Kohsaka
1 joint publications
Toshihide Ueno
1 joint publications
Hiroyuki Mano
1 joint publications
Birgit Wilding
1 joint publications
Lydia Woelflingseder
1 joint publications
Anke Baum
1 joint publications
Krzysztof Chylinski
1 joint publications
Gintautas Vainorius
1 joint publications
Neil Gibson
1 joint publications
Irene C Waizenegger
